When We Lose Antibiotics, Here’s Everything Else We’ll Lose Too

12/3/2013

This article discusses the growing concern of antibiotic resistance and the potential end of effective antibiotics. It highlights the overuse and misuse of antibiotics, leading to the evolution of drug-resistant bacteria. The article mentions the rise of superbugs, such as MRSA, and the limited options available for treatment. It also explores the economic factors that contribute to the development of new antibiotics, including the high cost of research and development. The article concludes by emphasizing the need for responsible antibiotic use and the development of alternative strategies to combat bacterial infections.

antibiotics ꞏ antibiotic resistance ꞏ drug resistance ꞏ superbugs ꞏ bacterial infection ꞏ medical research ꞏ drug development ꞏ healthcare ꞏ public health ꞏ pharmaceuticals ꞏ microbiology ꞏ infectious diseases ꞏ bacterial evolution ꞏ antibiotic efficacy ꞏ antibiotic misuse ꞏ antibiotic overuse ꞏ pathogenic bacteria ꞏ bacterial resistance mechanisms ꞏ antibiotic treatment ꞏ medicine ꞏ healthcare industry ꞏ pharmaceutical industry ꞏ bacterial genetics ꞏ antimicrobial agents ꞏ bacterial adaptation ꞏ antibiotic stewardship ꞏ drug-resistant bacteria ꞏ antibiotic crisis ꞏ bacterial infections ꞏ drug-resistant pathogens ꞏ emerging diseases ꞏ antibiotic discovery ꞏ antibiotic effectiveness ꞏ antibiotic alternatives ꞏ antimicrobial resistance ꞏ healthcare policy ꞏ bacterial virulence ꞏ antibiotic production ꞏ antibiotic pharmacology ꞏ drug-resistant infections ꞏ drug-resistant genes ꞏ bacterial mutation ꞏ antibiotic mechanism of action ꞏ antimicrobial therapy ꞏ bacterial eradication ꞏ antibiotic susceptibility ꞏ antibiotic resistance genes